← Evidence map

ArticleFrontiers in pharmacology2025

Key regulatory challenges in developing modified new chemical drugs in China: a national survey study.

Lixia Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40529492